PCM
FRLN

PenderFund Capital Management’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

PenderFund Capital Management’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-60,401
Closed -$509K – 143
2023
Q4 		$509K Buy
+60,401
New +$509K 0.17% 59